Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Open Label Study With YM150, a Direct Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness

NCT01028950 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT01028950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01028950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Open Label Study With YM150, a Direct Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness
Lead sponsor
Astellas Pharma Inc
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2009
Completion date
April 30, 2010
Enrollment
52 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

venous thromboembolism